BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Körbelin J, Dogbevia G, Michelfelder S, Ridder DA, Hunger A, Wenzel J, Seismann H, Lampe M, Bannach J, Pasparakis M, Kleinschmidt JA, Schwaninger M, Trepel M. A brain microvasculature endothelial cell-specific viral vector with the potential to treat neurovascular and neurological diseases. EMBO Mol Med 2016;8:609-25. [PMID: 27137490 DOI: 10.15252/emmm.201506078] [Cited by in Crossref: 70] [Cited by in F6Publishing: 64] [Article Influence: 11.7] [Reference Citation Analysis]
Number Citing Articles
1 Wang J, Cui Y, Yu Z, Wang W, Cheng X, Ji W, Guo S, Zhou Q, Wu N, Chen Y, Chen Y, Song X, Jiang H, Wang Y, Lan Y, Zhou B, Mao L, Li J, Yang H, Guo W, Yang X. Brain Endothelial Cells Maintain Lactate Homeostasis and Control Adult Hippocampal Neurogenesis. Cell Stem Cell 2019;25:754-767.e9. [DOI: 10.1016/j.stem.2019.09.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
2 Cui Y, Wang Y, Song X, Ning H, Zhang Y, Teng Y, Wang J, Yang X. Brain endothelial PTEN/AKT/NEDD4-2/MFSD2A axis regulates blood-brain barrier permeability. Cell Rep 2021;36:109327. [PMID: 34233198 DOI: 10.1016/j.celrep.2021.109327] [Reference Citation Analysis]
3 Nonnenmacher M, Wang W, Child MA, Ren XQ, Huang C, Ren AZ, Tocci J, Chen Q, Bittner K, Tyson K, Pande N, Chung CH, Paul SM, Hou J. Rapid evolution of blood-brain-barrier-penetrating AAV capsids by RNA-driven biopanning. Mol Ther Methods Clin Dev 2021;20:366-78. [PMID: 33553485 DOI: 10.1016/j.omtm.2020.12.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
4 Ravindra Kumar S, Miles TF, Chen X, Brown D, Dobreva T, Huang Q, Ding X, Luo Y, Einarsson PH, Greenbaum A, Jang MJ, Deverman BE, Gradinaru V. Multiplexed Cre-dependent selection yields systemic AAVs for targeting distinct brain cell types. Nat Methods 2020;17:541-50. [PMID: 32313222 DOI: 10.1038/s41592-020-0799-7] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 16.0] [Reference Citation Analysis]
5 Giannelli SG, Luoni M, Castoldi V, Massimino L, Cabassi T, Angeloni D, Demontis GC, Leocani L, Andreazzoli M, Broccoli V. Cas9/sgRNA selective targeting of the P23H Rhodopsin mutant allele for treating retinitis pigmentosa by intravitreal AAV9.PHP.B-based delivery. Human Molecular Genetics 2018;27:761-79. [DOI: 10.1093/hmg/ddx438] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 12.0] [Reference Citation Analysis]
6 Chung SH, Sin TN, Ngo T, Yiu G. CRISPR Technology for Ocular Angiogenesis. Front Genome Ed 2020;2:594984. [PMID: 34713223 DOI: 10.3389/fgeed.2020.594984] [Reference Citation Analysis]
7 Tan C, Lu NN, Wang CK, Chen DY, Sun NH, Lyu H, Körbelin J, Shi WX, Fukunaga K, Lu YM, Han F. Endothelium-Derived Semaphorin 3G Regulates Hippocampal Synaptic Structure and Plasticity via Neuropilin-2/PlexinA4. Neuron 2019;101:920-937.e13. [PMID: 30685224 DOI: 10.1016/j.neuron.2018.12.036] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 10.7] [Reference Citation Analysis]
8 Liu YB, Xu BC, Chen YT, Yuan X, Liu JY, Liu T, Du GZ, Jiang W, Yang Y, Zhu Y, Chen LJ, Ding BS, Wei YQ, Yang L. Directed evolution of AAV accounting for long-term and enhanced transduction of cardiovascular endothelial cells in vivo. Mol Ther Methods Clin Dev 2021;22:148-61. [PMID: 34485601 DOI: 10.1016/j.omtm.2021.05.015] [Reference Citation Analysis]
9 Hennigs JK, Matuszcak C, Trepel M, Körbelin J. Vascular Endothelial Cells: Heterogeneity and Targeting Approaches. Cells 2021;10:2712. [PMID: 34685692 DOI: 10.3390/cells10102712] [Reference Citation Analysis]
10 Oberle R, Kührer K, Österreicher T, Weber F, Steinbauer S, Udonta F, Wroblewski M, Ben-Batalla I, Hassl I, Körbelin J, Unseld M, Jauhiainen M, Plochberger B, Röhrl C, Hengstschläger M, Loges S, Stangl H. The HDL particle composition determines its antitumor activity in pancreatic cancer. Life Sci Alliance 2022;5:e202101317. [PMID: 35577388 DOI: 10.26508/lsa.202101317] [Reference Citation Analysis]
11 Tan P, He L, Huang Y, Zhou Y. Optophysiology: Illuminating cell physiology with optogenetics. Physiol Rev 2022. [PMID: 35072525 DOI: 10.1152/physrev.00021.2021] [Reference Citation Analysis]
12 Park ES, Kim S, Huang S, Yoo JY, Körbelin J, Lee TJ, Kaur B, Dash PK, Chen PR, Kim E. Selective Endothelial Hyperactivation of Oncogenic KRAS Induces Brain Arteriovenous Malformations in Mice. Ann Neurol 2021;89:926-41. [PMID: 33675084 DOI: 10.1002/ana.26059] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Tang W, Zillmann U, Sprengel R. Alternative Anesthesia of Neonatal Mice for Global rAAV Delivery in the Brain With Non-detectable Behavioral Interference in Adults. Front Behav Neurosci 2020;14:115. [PMID: 32760256 DOI: 10.3389/fnbeh.2020.00115] [Reference Citation Analysis]
14 Jiang Y, Müller K, Khan MA, Assmann JC, Lampe J, Kilau K, Richter M, Kleint M, Ridder DA, Hübner N, Schmidt-Supprian M, Wenzel J, Schwaninger M. Cerebral angiogenesis ameliorates pathological disorders in Nemo-deficient mice with small-vessel disease. J Cereb Blood Flow Metab 2021;41:219-35. [PMID: 32151223 DOI: 10.1177/0271678X20910522] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Behrmann L, Wellbrock J, Fiedler W. The bone marrow stromal niche: a therapeutic target of hematological myeloid malignancies. Expert Opin Ther Targets 2020;24:451-62. [PMID: 32188313 DOI: 10.1080/14728222.2020.1744850] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
16 van Lieshout LP, Soule G, Sorensen D, Frost KL, He S, Tierney K, Safronetz D, Booth SA, Kobinger GP, Qiu X, Wootton SK. Intramuscular Adeno-Associated Virus-Mediated Expression of Monoclonal Antibodies Provides 100% Protection Against Ebola Virus Infection in Mice. J Infect Dis 2018;217:916-25. [PMID: 29365142 DOI: 10.1093/infdis/jix644] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
17 Yang M, Sunderland K, Mao C. Virus-Derived Peptides for Clinical Applications. Chem Rev 2017;117:10377-402. [PMID: 28723101 DOI: 10.1021/acs.chemrev.7b00100] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
18 Remes A, Basha DI, Puehler T, Borowski C, Hille S, Kummer L, Wagner AH, Hecker M, Soethoff J, Lutter G, Frank D, Arif R, Frey N, Zaradzki M, Müller OJ. Alginate hydrogel polymers enable efficient delivery of a vascular-targeted AAV vector into aortic tissue. Mol Ther Methods Clin Dev 2021;21:83-93. [PMID: 33768132 DOI: 10.1016/j.omtm.2021.02.017] [Reference Citation Analysis]
19 Greenwood J, Hammarlund-Udenaes M, Jones HC, Stitt AW, Vandenbroucke RE, Romero IA, Campbell M, Fricker G, Brodin B, Manninga H, Gaillard PJ, Schwaninger M, Webster C, Wicher KB, Khrestchatisky M. Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017. Fluids Barriers CNS 2017;14:31. [PMID: 29110676 DOI: 10.1186/s12987-017-0079-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
20 Körbelin J, Trepel M. How to Successfully Screen Random Adeno-Associated Virus Display Peptide Libraries In Vivo. Hum Gene Ther Methods 2017;28:109-23. [PMID: 28193101 DOI: 10.1089/hgtb.2016.177] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
21 Terstappen GC, Meyer AH, Bell RD, Zhang W. Strategies for delivering therapeutics across the blood-brain barrier. Nat Rev Drug Discov 2021;20:362-83. [PMID: 33649582 DOI: 10.1038/s41573-021-00139-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
22 Zhang X, Chai Z, Lee Dobbins A, Itano MS, Askew C, Miao Z, Niu H, Samulski RJ, Li C. Customized blood-brain barrier shuttle peptide to increase AAV9 vector crossing the BBB and augment transduction in the brain. Biomaterials 2021;281:121340. [PMID: 34998171 DOI: 10.1016/j.biomaterials.2021.121340] [Reference Citation Analysis]
23 Song X, Cui Y, Wang Y, Zhang Y, He Q, Yu Z, Xu C, Ning H, Han Y, Cai Y, Cheng X, Wang J, Teng Y, Yang X, Wang J. Genome Editing with AAV-BR1-CRISPR in Postnatal Mouse Brain Endothelial Cells. Int J Biol Sci 2022;18:652-60. [PMID: 35002515 DOI: 10.7150/ijbs.64188] [Reference Citation Analysis]
24 Duarte Azevedo M, Sander S, Jeanneret C, Olfat S, Tenenbaum L. Selective targeting of striatal parvalbumin-expressing interneurons for transgene delivery. J Neurosci Methods 2021;354:109105. [PMID: 33652020 DOI: 10.1016/j.jneumeth.2021.109105] [Reference Citation Analysis]
25 Körbelin J, Dogbevia G, Michelfelder S, Ridder DA, Hunger A, Wenzel J, Seismann H, Lampe M, Bannach J, Pasparakis M, Kleinschmidt JA, Schwaninger M, Trepel M. A brain microvasculature endothelial cell-specific viral vector with the potential to treat neurovascular and neurological diseases. EMBO Mol Med 2016;8:609-25. [PMID: 27137490 DOI: 10.15252/emmm.201506078] [Cited by in Crossref: 70] [Cited by in F6Publishing: 64] [Article Influence: 11.7] [Reference Citation Analysis]
26 Li C, Samulski RJ. Engineering adeno-associated virus vectors for gene therapy. Nat Rev Genet 2020;21:255-72. [DOI: 10.1038/s41576-019-0205-4] [Cited by in Crossref: 171] [Cited by in F6Publishing: 156] [Article Influence: 85.5] [Reference Citation Analysis]
27 Marchiò S, Sidman RL, Arap W, Pasqualini R. Brain endothelial cell-targeted gene therapy of neurovascular disorders. EMBO Mol Med 2016;8:592-4. [PMID: 27189170 DOI: 10.15252/emmm.201606407] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
28 Hay BA, Li J, Guo M. Vectored gene delivery for lifetime animal contraception: Overview and hurdles to implementation. Theriogenology 2018;112:63-74. [DOI: 10.1016/j.theriogenology.2017.11.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
29 Wenzel J, Lampe J, Müller-Fielitz H, Schuster R, Zille M, Müller K, Krohn M, Körbelin J, Zhang L, Özorhan Ü, Neve V, Wagner JUG, Bojkova D, Shumliakivska M, Jiang Y, Fähnrich A, Ott F, Sencio V, Robil C, Pfefferle S, Sauve F, Coêlho CFF, Franz J, Spiecker F, Lembrich B, Binder S, Feller N, König P, Busch H, Collin L, Villaseñor R, Jöhren O, Altmeppen HC, Pasparakis M, Dimmeler S, Cinatl J, Püschel K, Zelic M, Ofengeim D, Stadelmann C, Trottein F, Nogueiras R, Hilgenfeld R, Glatzel M, Prevot V, Schwaninger M. The SARS-CoV-2 main protease Mpro causes microvascular brain pathology by cleaving NEMO in brain endothelial cells. Nat Neurosci 2021;24:1522-33. [PMID: 34675436 DOI: 10.1038/s41593-021-00926-1] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
30 Körbelin J, Hunger A, Alawi M, Sieber T, Binder M, Trepel M. Optimization of design and production strategies for novel adeno-associated viral display peptide libraries. Gene Ther 2017;24:470-81. [PMID: 28622288 DOI: 10.1038/gt.2017.51] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
31 Liu D, Zhu M, Zhang Y, Diao Y. Crossing the blood-brain barrier with AAV vectors. Metab Brain Dis 2021;36:45-52. [PMID: 33201426 DOI: 10.1007/s11011-020-00630-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
32 Wagner HJ, Weber W, Fussenegger M. Synthetic Biology: Emerging Concepts to Design and Advance Adeno-Associated Viral Vectors for Gene Therapy. Adv Sci (Weinh) 2021;8:2004018. [PMID: 33977059 DOI: 10.1002/advs.202004018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Nectow AR, Nestler EJ. Viral tools for neuroscience. Nat Rev Neurosci 2020;21:669-81. [PMID: 33110222 DOI: 10.1038/s41583-020-00382-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
34 Huang R, Hu Z, Feng Y, Yu L, Li X. The Transcription Factor IRF6 Co-Represses PPARγ-Mediated Cytoprotection in Ischemic Cerebrovascular Endothelial Cells. Sci Rep 2017;7:2150. [PMID: 28526834 DOI: 10.1038/s41598-017-02095-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
35 Brown D, Altermatt M, Dobreva T, Chen S, Wang A, Thomson M, Gradinaru V. Deep Parallel Characterization of AAV Tropism and AAV-Mediated Transcriptional Changes via Single-Cell RNA Sequencing. Front Immunol 2021;12:730825. [PMID: 34759919 DOI: 10.3389/fimmu.2021.730825] [Reference Citation Analysis]
36 Meng Y, Sun D, Qin Y, Dong X, Luo G, Liu Y. Cell-penetrating peptides enhance the transduction of adeno-associated virus serotype 9 in the central nervous system. Mol Ther Methods Clin Dev 2021;21:28-41. [PMID: 33768127 DOI: 10.1016/j.omtm.2021.02.019] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Dogbevia GK, Töllner K, Körbelin J, Bröer S, Ridder DA, Grasshoff H, Brandt C, Wenzel J, Straub BK, Trepel M, Löscher W, Schwaninger M. Gene therapy decreases seizures in a model of Incontinentia pigmenti: Gene Therapy of Incontinentia pigmenti. Ann Neurol 2017;82:93-104. [DOI: 10.1002/ana.24981] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
38 Huang Q, Chan KY, Tobey IG, Chan YA, Poterba T, Boutros CL, Balazs AB, Daneman R, Bloom JM, Seed C, Deverman BE. Delivering genes across the blood-brain barrier: LY6A, a novel cellular receptor for AAV-PHP.B capsids. PLoS One 2019;14:e0225206. [PMID: 31725765 DOI: 10.1371/journal.pone.0225206] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 16.7] [Reference Citation Analysis]
39 Ding Y, Shusta EV, Palecek SP. Integrating in vitro disease models of the neurovascular unit into discovery and development of neurotherapeutics. Curr Opin Biomed Eng 2021;20:100341. [PMID: 34693102 DOI: 10.1016/j.cobme.2021.100341] [Reference Citation Analysis]
40 Ingusci S, Verlengia G, Soukupova M, Zucchini S, Simonato M. Gene Therapy Tools for Brain Diseases. Front Pharmacol 2019;10:724. [PMID: 31312139 DOI: 10.3389/fphar.2019.00724] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 15.3] [Reference Citation Analysis]
41 Ren AA, Snellings DA, Su YS, Hong CC, Castro M, Tang AT, Detter MR, Hobson N, Girard R, Romanos S, Lightle R, Moore T, Shenkar R, Benavides C, Beaman MM, Müller-Fielitz H, Chen M, Mericko P, Yang J, Sung DC, Lawton MT, Ruppert JM, Schwaninger M, Körbelin J, Potente M, Awad IA, Marchuk DA, Kahn ML. PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism. Nature 2021;594:271-6. [PMID: 33910229 DOI: 10.1038/s41586-021-03562-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
42 Eichhoff AM, Börner K, Albrecht B, Schäfer W, Baum N, Haag F, Körbelin J, Trepel M, Braren I, Grimm D, Adriouch S, Koch-Nolte F. Nanobody-Enhanced Targeting of AAV Gene Therapy Vectors. Mol Ther Methods Clin Dev 2019;15:211-20. [PMID: 31687421 DOI: 10.1016/j.omtm.2019.09.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
43 Garello F, Pagoto A, Arena F, Buffo A, Blasi F, Alberti D, Terreno E. MRI visualization of neuroinflammation using VCAM-1 targeted paramagnetic micelles. Nanomedicine: Nanotechnology, Biology and Medicine 2018;14:2341-50. [DOI: 10.1016/j.nano.2017.10.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
44 Puhl DL, D'Amato AR, Gilbert RJ. Challenges of gene delivery to the central nervous system and the growing use of biomaterial vectors. Brain Res Bull 2019;150:216-30. [PMID: 31173859 DOI: 10.1016/j.brainresbull.2019.05.024] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
45 Järvinen TAH, Rashid J, Valmari T, May U, Ahsan F. Systemically Administered, Target-Specific Therapeutic Recombinant Proteins and Nanoparticles for Regenerative Medicine. ACS Biomater Sci Eng 2017;3:1273-82. [DOI: 10.1021/acsbiomaterials.6b00746] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 2.6] [Reference Citation Analysis]
46 Zou C, Mifflin L, Hu Z, Zhang T, Shan B, Wang H, Xing X, Zhu H, Adiconis X, Levin JZ, Li F, Liu CF, Liu JS, Yuan J. Reduction of mNAT1/hNAT2 Contributes to Cerebral Endothelial Necroptosis and Aβ Accumulation in Alzheimer's Disease. Cell Rep 2020;33:108447. [PMID: 33296651 DOI: 10.1016/j.celrep.2020.108447] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
47 Strobel B, Zuckschwerdt K, Zimmermann G, Mayer C, Eytner R, Rechtsteiner P, Kreuz S, Lamla T. Standardized, Scalable, and Timely Flexible Adeno-Associated Virus Vector Production Using Frozen High-Density HEK-293 Cell Stocks and CELLdiscs. Hum Gene Ther Methods 2019;30:23-33. [PMID: 30693792 DOI: 10.1089/hgtb.2018.228] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 10.5] [Reference Citation Analysis]
48 Alvarez-Vergara MI, Rosales-Nieves AE, March-Diaz R, Rodriguez-Perinan G, Lara-Ureña N, Ortega-de San Luis C, Sanchez-Garcia MA, Martin-Bornez M, Gómez-Gálvez P, Vicente-Munuera P, Fernandez-Gomez B, Marchena MA, Bullones-Bolanos AS, Davila JC, Gonzalez-Martinez R, Trillo-Contreras JL, Sanchez-Hidalgo AC, Del Toro R, Scholl FG, Herrera E, Trepel M, Körbelin J, Escudero LM, Villadiego J, Echevarria M, de Castro F, Gutierrez A, Rabano A, Vitorica J, Pascual A. Non-productive angiogenesis disassembles Aß plaque-associated blood vessels. Nat Commun 2021;12:3098. [PMID: 34035282 DOI: 10.1038/s41467-021-23337-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 Chowdhury EA, Meno-Tetang G, Chang HY, Wu S, Huang HW, Jamier T, Chandran J, Shah DK. Current progress and limitations of AAV mediated delivery of protein therapeutic genes and the importance of developing quantitative pharmacokinetic/pharmacodynamic (PK/PD) models. Adv Drug Deliv Rev 2021;170:214-37. [PMID: 33486008 DOI: 10.1016/j.addr.2021.01.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
50 Blessing D, Déglon N. Adeno-associated virus and lentivirus vectors: a refined toolkit for the central nervous system. Curr Opin Virol 2016;21:61-6. [PMID: 27559630 DOI: 10.1016/j.coviro.2016.08.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
51 Frøslev P, Franzyk H, Ozgür B, Brodin B, Kristensen M. Highly cationic cell-penetrating peptides affect the barrier integrity and facilitates mannitol permeation in a human stem cell-based blood-brain barrier model. Eur J Pharm Sci 2021;168:106054. [PMID: 34728364 DOI: 10.1016/j.ejps.2021.106054] [Reference Citation Analysis]
52 Müller K, Courtois G, Ursini MV, Schwaninger M. New Insight Into the Pathogenesis of Cerebral Small-Vessel Diseases. Stroke 2017;48:520-7. [PMID: 28082670 DOI: 10.1161/STROKEAHA.116.012888] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
53 Remes A, Basha D, Frey N, Wagner A, Müller O. Gene transfer to the vascular system: Novel translational perspectives for vascular diseases. Biochemical Pharmacology 2020;182:114265. [DOI: 10.1016/j.bcp.2020.114265] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
54 Macdonald J, Marx J, Büning H. Capsid-Engineering for Central Nervous System-Directed Gene Therapy with Adeno-Associated Virus Vectors. Hum Gene Ther 2021;32:1096-119. [PMID: 34662226 DOI: 10.1089/hum.2021.169] [Reference Citation Analysis]
55 Bodemer C, Diociaiuti A, Hadj-Rabia S, Robert MP, Desguerre I, Manière MC, de la Dure-Molla M, De Liso P, Federici M, Galeotti A, Fusco F, Fraitag S, Demily C, Taieb C, Valeria Ursini M, El Hachem M, Steffann J. Multidisciplinary consensus recommendations from a European network for the diagnosis and practical management of patients with incontinentia pigmenti. J Eur Acad Dermatol Venereol 2020;34:1415-24. [PMID: 32678511 DOI: 10.1111/jdv.16403] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
56 Chen W, Yao S, Wan J, Tian Y, Huang L, Wang S, Akter F, Wu Y, Yao Y, Zhang X. BBB-crossing adeno-associated virus vector: An excellent gene delivery tool for CNS disease treatment. J Control Release 2021;333:129-38. [PMID: 33775685 DOI: 10.1016/j.jconrel.2021.03.029] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
57 Wu G, Jiang Q, Cui T, Liu X, Gong D, Yin Y, Wang C, Wang T, Lu Y, Zhu D, Han F. The glymphatic system delivery enhances the transduction efficiency of AAV1 to brain endothelial cells in adult mice. J Neurosci Methods 2019;328:108441. [PMID: 31574288 DOI: 10.1016/j.jneumeth.2019.108441] [Reference Citation Analysis]
58 Weinmann J, Weis S, Sippel J, Tulalamba W, Remes A, El Andari J, Herrmann AK, Pham QH, Borowski C, Hille S, Schönberger T, Frey N, Lenter M, VandenDriessche T, Müller OJ, Chuah MK, Lamla T, Grimm D. Identification of a myotropic AAV by massively parallel in vivo evaluation of barcoded capsid variants. Nat Commun 2020;11:5432. [PMID: 33116134 DOI: 10.1038/s41467-020-19230-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
59 Rittiner JE, Moncalvo M, Chiba-Falek O, Kantor B. Gene-Editing Technologies Paired With Viral Vectors for Translational Research Into Neurodegenerative Diseases. Front Mol Neurosci 2020;13:148. [PMID: 32903507 DOI: 10.3389/fnmol.2020.00148] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
60 Santisteban MM, Ahn SJ, Lane D, Faraco G, Garcia-Bonilla L, Racchumi G, Poon C, Schaeffer S, Segarra SG, Körbelin J, Anrather J, Iadecola C. Endothelium-Macrophage Crosstalk Mediates Blood-Brain Barrier Dysfunction in Hypertension. Hypertension 2020;76:795-807. [PMID: 32654560 DOI: 10.1161/HYPERTENSIONAHA.120.15581] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
61 Mehina EMF, Taylor S, Boghozian R, White E, Choi SE, Cheema MS, Korbelin J, Brown CE. Invasion of phagocytic Galectin 3 expressing macrophages in the diabetic brain disrupts vascular repair. Sci Adv 2021;7:eabg2712. [PMID: 34407943 DOI: 10.1126/sciadv.abg2712] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
62 Liu XX, Yang L, Shao LX, He Y, Wu G, Bao YH, Lu NN, Gong DM, Lu YP, Cui TT, Sun NH, Chen DY, Shi WX, Fukunaga K, Chen HS, Chen Z, Han F, Lu YM. Endothelial Cdk5 deficit leads to the development of spontaneous epilepsy through CXCL1/CXCR2-mediated reactive astrogliosis. J Exp Med 2020;217:e20180992. [PMID: 31699822 DOI: 10.1084/jem.20180992] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
63 Deverman BE, Ravina BM, Bankiewicz KS, Paul SM, Sah DWY. Gene therapy for neurological disorders: progress and prospects. Nat Rev Drug Discov 2018;17:641-59. [DOI: 10.1038/nrd.2018.110] [Cited by in Crossref: 109] [Cited by in F6Publishing: 99] [Article Influence: 27.3] [Reference Citation Analysis]
64 Nikolakopoulou AM, Wang Y, Ma Q, Sagare AP, Montagne A, Huuskonen MT, Rege SV, Kisler K, Dai Z, Körbelin J, Herz J, Zhao Z, Zlokovic BV. Endothelial LRP1 protects against neurodegeneration by blocking cyclophilin A. J Exp Med 2021;218:e20202207. [PMID: 33533918 DOI: 10.1084/jem.20202207] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
65 Bozoglu T, Lee S, Ziegler T, Jurisch V, Maas S, Baehr A, Hinkel R, Hoenig A, Hariharan A, Kim CI, Decker S, Sami H, Koppara T, Oellinger R, Müller OJ, Frank D, Megens R, Nelson P, Weber C, Schnieke A, Sperandio M, Santamaria G, Rad R, Moretti A, Laugwitz K, Soehnlein O, Ogris M, Kupatt C. Endothelial Retargeting of AAV9 In Vivo. Advanced Science. [DOI: 10.1002/advs.202103867] [Reference Citation Analysis]
66 Mushimiyimana I, Niskanen H, Beter M, Laakkonen JP, Kaikkonen MU, Ylä-Herttuala S, Laham-Karam N. Characterization of a functional endothelial super-enhancer that regulates ADAMTS18 and angiogenesis. Nucleic Acids Res 2021:gkab633. [PMID: 34320216 DOI: 10.1093/nar/gkab633] [Reference Citation Analysis]
67 Kimura S, Harashima H. Current Status and Challenges Associated with CNS-Targeted Gene Delivery across the BBB. Pharmaceutics 2020;12:E1216. [PMID: 33334049 DOI: 10.3390/pharmaceutics12121216] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
68 Graßhoff H, Müller-Fielitz H, Dogbevia GK, Körbelin J, Bannach J, Vahldieck CM, Kusche-Vihrog K, Jöhren O, Müller OJ, Nogueiras R, Prevot V, Schwaninger M. Short regulatory DNA sequences to target brain endothelial cells for gene therapy. J Cereb Blood Flow Metab 2021;:271678X211039617. [PMID: 34427142 DOI: 10.1177/0271678X211039617] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Körbelin J, Schwaninger M, Trepel M. Vascular-targeted recombinant adeno-associated viral vectors for the treatment of rare diseases. Rare Diseases 2016;4:e1220470. [DOI: 10.1080/21675511.2016.1220470] [Reference Citation Analysis]
70 Hede E, Christiansen CB, Heegaard CW, Moos T, Burkhart A. Gene therapy to the blood-brain barrier with resulting protein secretion as a strategy for treatment of Niemann Picks type C2 disease. J Neurochem 2021;156:290-308. [PMID: 32072649 DOI: 10.1111/jnc.14982] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
71 Noroozian Z, Xhima K, Huang Y, Kaspar BK, Kügler S, Hynynen K, Aubert I. MRI-Guided Focused Ultrasound for Targeted Delivery of rAAV to the Brain. Methods Mol Biol 2019;1950:177-97. [PMID: 30783974 DOI: 10.1007/978-1-4939-9139-6_10] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
72 Ivanova E, Corona C, Eleftheriou CG, Stout RF Jr, Körbelin J, Sagdullaev BT. AAV-BR1 targets endothelial cells in the retina to reveal their morphological diversity and to deliver Cx43. J Comp Neurol 2021. [PMID: 34811744 DOI: 10.1002/cne.25277] [Reference Citation Analysis]
73 D'Souza A, Dave KM, Stetler RA, S Manickam D. Targeting the blood-brain barrier for the delivery of stroke therapies. Adv Drug Deliv Rev. 2021;171:332-351. [PMID: 33497734 DOI: 10.1016/j.addr.2021.01.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
74 Chen DY, Sun NH, Chen X, Gong JJ, Yuan ST, Hu ZZ, Lu NN, Körbelin J, Fukunaga K, Liu QH, Lu YM, Han F. Endothelium-derived semaphorin 3G attenuates ischemic retinopathy by coordinating β-catenin-dependent vascular remodeling. J Clin Invest 2021;131:135296. [PMID: 33586674 DOI: 10.1172/JCI135296] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
75 Helms HCC, Kristensen M, Saaby L, Fricker G, Brodin B. Drug Delivery Strategies to Overcome the Blood-Brain Barrier (BBB). Handb Exp Pharmacol 2020. [PMID: 33367937 DOI: 10.1007/164_2020_403] [Reference Citation Analysis]
76 Dogbevia G, Grasshoff H, Othman A, Penno A, Schwaninger M. Brain endothelial specific gene therapy improves experimental Sandhoff disease. J Cereb Blood Flow Metab 2020;40:1338-50. [PMID: 31357902 DOI: 10.1177/0271678X19865917] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]